← Companies
Legend Biotech Corp
Data as of Sep 17, 2026
Lobbying
$650,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 15, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$650K7 filings
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 15, 2026 | HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $90,000 |
| Apr 13, 2026 | HOGAN LOVELLS US LLP for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $90,000 |
| Jan 20, 2026 | HOGAN LOVELLS US LLP for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $90,000 |
| Oct 16, 2025 | HOGAN LOVELLS US LLP for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $110,000 |
| Jul 16, 2025 | HOGAN LOVELLS US LLP for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $70,000 |
| Apr 15, 2025 | HOGAN LOVELLS US LLP for LEGEND BIOTECH CORPORATION Health Issues Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare | $100,000 |